Petrylak, D : rechercher sur Z-Library

Le plus grand référentiel d'articles scientifiques au monde. 70,000,000+ d'articles gratuitement.

Don't use scam websites

Livres
Articles (256)
Les plus populaires
Liste
- Liste
- Tableau

1

A Phase I Trial of Pox PSA vaccines (PROSTVAC®-VF) with B7-1, ICAM-1, and LFA-3 co-stimulatory molecules (TRICOM™) in Patients with Prostate Cancer

RS DiPaola, M Plante, H Kaufman, DP Petrylak, R Israeli, E Lattime, K Manson, T Schuetz

Journal:

Journal of Translational Medicine

Année:

2006

Langue:

english

Fichier:

PDF, 224 KB

english, 2006

2

Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial

Balar, Arjun V, Galsky, Matthew D, Rosenberg, Jonathan E, Powles, Thomas, Petrylak, Daniel P, Bellmunt, Joaquim, Loriot, Yohann, Necchi, Andrea, Hoffman-Censits, Jean, Perez-Gracia, Jose Luis, Dawson,

Journal:

Année:

2017

Langue:

english

Fichier:

PDF, 598 KB

english, 2017

3

Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma

Bellmunt, Joaquim, de Wit, Ronald, Vaughn, David J., Fradet, Yves, Lee, Jae-Lyun, Fong, Lawrence, Vogelzang, Nicholas J., Climent, Miguel A., Petrylak, Daniel P., Choueiri, Toni K., Necchi, Andrea, Ge

Journal:

New England Journal of Medicine

Année:

2017

Langue:

english

Fichier:

PDF, 381 KB

english, 2017

4

MP78-07 CLINICAL CHARACTERISTICS ASSOCIATED WITH EARLY PROGRESSION OR LONG-TERM RESPONSE FROM THE PHASE II IMVIGOR210 STUDY: ATEZOLIZUMAB IN LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA

Joseph, Richard W., Loriot, Yohann, Perez-Gracia, Jose Luis, Dreicer, Robert, Petrylak, Daniel P., van der Heijden, Michiel S., Hoffman-Censits, Jean, Shen, Xiadong, Fear, Simon, Pavlova, Julie, Rosen

Journal:

The Journal of Urology

Année:

2018

Langue:

english

Fichier:

PDF, 197 KB

english, 2018

5

Docetaxel-based chemotherapy trials in androgen-independent prostate cancer: First demonstration of a survival benefit

Daniel P. Petrylak

Journal:

Current Oncology Reports

Année:

2005

Langue:

english

Fichier:

PDF, 182 KB

english, 2005

6

Long-term Clinical Outcomes of a Phase I Trial of Intravesical Docetaxel in the Management of Non–muscle-invasive Bladder Cancer Refractory to Standard Intravesical Therapy

Melissa A. Laudano, Lamont J. Barlow, Alana M. Murphy, Daniel P. Petrylak, Manisha Desai, Mitchell C. Benson, James M. McKiernan

Journal:

Année:

2010

Langue:

english

Fichier:

PDF, 194 KB

english, 2010

7

New Data, New Paradigms for Treating Prostate Cancer Patients—VI: Novel Hormonal Therapy Approaches

Robert Dreicer, Dean F. Bajorin, David G. McLeod, Daniel P. Petrylak, Judd W. Moul

Journal:

Année:

2011

Langue:

english

Fichier:

PDF, 413 KB

english, 2011

8

The utility of prostate-specific antigen in the management of advanced prostate cancer

Crawford, E. David, Bennett, Charles L., Andriole, Gerald L., Garnick, Marc B., Petrylak, Daniel P.

Journal:

BJU International

Année:

2013

Langue:

english

Fichier:

PDF, 165 KB

english, 2013

9

1706 CARBOPLATIN VS. CISPLATIN-BASED CHEMOTHERAPY IN THE PERIOPERATIVE TREATMENT OF MUSCLE-INVASIVE BLADDER CANCER

Wosnitzer, Matthew, Hruby, Gregory, Cordon-Cardo, Carlos, Benson, Mitchell, Petrylak, Daniel, McKiernan, James

Journal:

The Journal of Urology

Année:

2010

Langue:

english

Fichier:

PDF, 52 KB

english, 2010

10

Navigating the evolving therapeutic landscape in advanced prostate cancer

Crawford, E. David, Petrylak, Daniel, Sartor, Oliver

Journal:

Urologic Oncology: Seminars and Original Investigations

Année:

2017

Langue:

english

Fichier:

PDF, 1.53 MB

english, 2017

11

Introduction to the Yale Precision Medicine Tumor Board

Cecchini, Michael, Walther, Zenta, Sklar, Jeffrey L, Bindra, Ranjit S, Petrylak, Daniel P, Eder, Joseph P, Goldberg, Sarah B

Journal:

The Lancet Oncology

Année:

2018

Langue:

english

Fichier:

PDF, 725 KB

english, 2018

12

Yale Cancer Center Precision Medicine Tumor Board: two patients, one targeted therapy, different outcomes

Cecchini, Michael, Walther, Zenta, Sklar, Jeffrey L, Bindra, Ranjit S, Petrylak, Daniel P, Eder, Joseph P, Goldberg, Sarah B

Journal:

The Lancet Oncology

Année:

2018

Langue:

english

Fichier:

PDF, 58 KB

english, 2018

13

EV-103 Study: A phase 1b dose-escalation and dose-expansion study of enfortumab vedotin in combination with immune checkpoint inhibitor (CPI) therapy for treatment of patients with locally advanced or metastatic urothelial cancer

Hoimes, C.J., Petrylak, D., Flaig, T., Carret, A.-S., Melhem-Bertrandt, A., Gartner, E., Rosenberg, J.

Journal:

European Urology Supplements

Année:

2018

Langue:

english

Fichier:

PDF, 83 KB

english, 2018

14

When and How to Use PARP Inhibitors in Prostate Cancer: A Systematic Review of the Literature with an Update on On-Going Trials

Antonarakis, Emmanuel S., Gomella, Leonard G., Petrylak, Daniel P.

Journal:

European Urology Oncology

Année:

2020

Fichier:

PDF, 1.01 MB

2020

15

EV-201: Long-term results of enfortumab vedotin monotherapy for locally advanced or metastatic urothelial cancer previously treated with platinum and PD-1/PD-L1 inhibitors

O'Donnell, P., Galsky, M.D., Rosenberg, J.E., Petrylak, D.P., Balar, A.V., McGregor, B.A., Heath, E., Yu, E.Y., Quinn, D.I., Hahn, N.M., Campbell, M., Liang, S-Y., Steinberg, J., Loriot, Y.

Journal:

Annals of Oncology

Année:

2020

Fichier:

PDF, 96 KB

2020

16

Interleukin-2 enhances biopterins and catecholamines production during adoptive immunotherapy for various cancers

Herman Baker, StuarT L. Marcus, Oscar Frank, Daniel P. Petrylak, Barbara Deangelis, Janice P. Dutcher, Peter H. Wiernik

Journal:

Année:

1989

Langue:

english

Fichier:

PDF, 562 KB

english, 1989

17

Cytotoxic chemotherapy for advanced hormone-resistant prostate cancer

Alan Yagoda, Daniel Petrylak

Journal:

Année:

1993

Langue:

english

Fichier:

PDF, 1.19 MB

english, 1993

18

Phase I trial of interferon α2b and liposome-encapsulated all-trans retinoic acid in the treatment of patients with advanced renal cell carcinoma

Jonathan S. Goldberg, Manuel Vargas, Alyssa S. Rosmarin, Matthew I. Milowsky, Nicholas Papanicoloau, Lorraine J. Gudas, Gary Shelton, Kevie Feit, Daniel Petrylak, David M. Nanus

Journal:

Année:

2002

Langue:

english

Fichier:

PDF, 317 KB

english, 2002

19

A Phase II trial of docetaxel and estramustine in patients with refractory metastatic breast carcinoma

Amy D. Tiersten, Caron Nelsen, Susan Talbot, Linda Vahdat, Robert Fine, Andrea Troxel, Lois Brafman, Laureen Shriberg, Karen Antman, Daniel P. Petrylak

Journal:

Année:

2003

Langue:

english

Fichier:

PDF, 86 KB

english, 2003

20

Southwest Oncology Group studies in bladder cancer

E. David Crawford, David P. Wood, Daniel P. Petrylak, Jennifer Scott, Charles A. Coltman Jr., Derek Raghavan

Journal:

Année:

2003

Langue:

english

Fichier:

PDF, 111 KB

english, 2003

21

Quality of life impact of three different doses of suramin in patients with metastatic hormone-refractory prostate carcinoma : Results of Intergroup 0159/Cancer and Leukemia Group B 9480

Tim A. Ahles, James E. Herndon II, Eric J. Small, Nicholas J. Vogelzang, Alice B. Kornblith, Mark J. Ratain, Walter Stadler, David Palchak, M. Ernest Marshall, George Wilding, Daniel Petrylak, Jimmie

Journal:

Année:

2004

Langue:

english

Fichier:

PDF, 86 KB

english, 2004

22

Phase II trial of carboplatin and paclitaxel in cisplatin-pretreated advanced transitional cell carcinoma : A Southwest Oncology Group study

Ulka N. Vaishampayan, James R. Faulkner, Eric J. Small, Bruce G. Redman, Wayne L. Keiser, Daniel P. Petrylak, E. David Crawford

Journal:

Année:

2005

Langue:

english

Fichier:

PDF, 86 KB

english, 2005

23

A pilot study of the vulnerable elders survey-13 compared with the comprehensive geriatric assessment for identifying disability in older patients with prostate cancer who receive androgen ablation

Supriya G. Mohile, Kathryn Bylow, William Dale, James Dignam, Kandis Martin, Daniel P. Petrylak, Walter M. Stadler, Miriam Rodin

Journal:

Année:

2007

Langue:

english

Fichier:

PDF, 133 KB

english, 2007

24

Intermittent chemotherapy in patients with metastatic androgen-independent prostate cancer : Results from ASCENT, a double-blinded, randomized comparison of high-dose calcitriol plus docetaxel with placebo plus docetaxel

Tomasz M. Beer, Christopher W. Ryan, Peter M. Venner, Daniel P. Petrylak, Gurkamal S. Chatta, J. Dean Ruether, Kim N. Chi, James Young, W. David Henner

Journal:

Année:

2008

Langue:

english

Fichier:

PDF, 109 KB

english, 2008

25

Vinflunine in platinum-pretreated patients with locally advanced or metastatic urothelial carcinoma : Results of a large phase 2 study

David J. Vaughn, Sandy Srinivas, Walter M. Stadler, Roberto Pili, Daniel Petrylak, Cora N. Sternberg, David C. Smith, Sarah Ringuette, Edwin de Wit, Virginie Pautret, Claude George

Journal:

Année:

2009

Langue:

english

Fichier:

PDF, 162 KB

english, 2009

26

A comparison of the outcomes of neoadjuvant and adjuvant chemotherapy for clinical T2-T4aN0-N2M0 bladder cancer

Matthew S. Wosnitzer, Gregory W. Hruby, Alana M. Murphy, Lamont J. Barlow, Carlos Cordon-Cardo, Mahesh Mansukhani, Daniel P. Petrylak, Mitchell C. Benson, James M. McKiernan

Journal:

Année:

2012

Langue:

english

Fichier:

PDF, 213 KB

english, 2012

27

Type III neuregulin-1 promotes oligodendrocyte myelination

Carla Taveggia, Pratik Thaker, Ashley Petrylak, Gregg L. Caporaso, Arrel Toews, Douglas L. Falls, Steven Einheber, James L. Salzer

Journal:

Année:

2008

Langue:

english

Fichier:

PDF, 724 KB

english, 2008

28

Perioperative chemotherapy for bladder cancer

Guru Sonpavde, Daniel P. Petrylak

Journal:

Critical Reviews in Oncology/Hematology

Année:

2006

Langue:

english

Fichier:

PDF, 131 KB

english, 2006

29

Photochemical studies of M(CO)6 (M = Cr, Mo, W) at low temperature in solution. Infrared spectra of M(CO)5 (solvent) (solvent = methylcyclohexane, methylene chloride) and W(CO)5L (L = aromatic hydrocarbon)

David R Tyler, Daniel P Petrylak

Journal:

Journal of Organometallic Chemistry

Année:

1981

Langue:

english

Fichier:

PDF, 675 KB

english, 1981

30

Which patients with newly diagnosed prostate cancer need a radionuclide bone scan? An analysis based on 631 patients

Nancy Lee, Rashid Fawaaz, Carl A Olsson, Mitchell C Benson, Daniel P Petrylak, Peter B Schiff, Emilia Bagiella, Arun Singh, Ronald D Ennis

Journal:

International Journal of Radiation Oncology*Biology*Physics

Année:

2000

Langue:

english

Fichier:

PDF, 59 KB

english, 2000

31

Chemotherapy for androgen-independent prostate cancer

Daniel P. Petrylak

Journal:

World Journal of Urology

Année:

2005

Langue:

english

Fichier:

PDF, 172 KB

english, 2005

32

Carcinomatous Meningitis from Urachal Carcinoma: The First Reported Case

Shearwood McClelland, Rebeca E Garcia, Sara E Monaco, James E Goldman, Ty J Olson, Grace H Kim, Daniel P Petrylak, Robert R Goodman

Journal:

Journal of Neuro-Oncology

Année:

2006

Langue:

english

Fichier:

PDF, 265 KB

english, 2006

33

Cytotoxic chemotherapy for prostate cancer: Who and when?

Rebecca A. Moss, Daniel P. Petrylak

Journal:

Current Treatment Options in Oncology

Année:

2006

Langue:

english

Fichier:

PDF, 260 KB

english, 2006

34

Combination therapy in hormone-refractory prostate cancer

Daniel P. Petrylak

Journal:

Current Oncology Reports

Année:

2001

Langue:

english

Fichier:

PDF, 45 KB

english, 2001

35

Transitional cell carcinoma of the bladder: New approaches to the treatment of advanced disease

Daniel P. Petrylak

Journal:

Current Oncology Reports

Année:

2001

Langue:

english

Fichier:

PDF, 143 KB

english, 2001

36

Early chemohormonal therapy in prostate cancer: Preliminary data and randomized trials

Daniel P. Petrylak

Journal:

Current Oncology Reports

Année:

2003

Langue:

english

Fichier:

PDF, 117 KB

english, 2003

37

Complications of androgen deprivation therapy in men with prostate cancer

Allen C. Chen, Daniel P. Petrylak

Journal:

Current Oncology Reports

Année:

2004

Langue:

english

Fichier:

PDF, 315 KB

english, 2004

38

Adjuvant chemotherapy for transitional cell carcinoma of the bladder: Paradigms for the design of clinical trials

Michelle Boyar, Daniel P. Petrylak

Journal:

Current Oncology Reports

Année:

2005

Langue:

english

Fichier:

PDF, 358 KB

english, 2005

39

Management of asymptomatic rise in prostatic-specific antigen in patients with prostate cancer

Supriya G. Mohile, Daniel P. Petrylak

Journal:

Current Oncology Reports

Année:

2006

Langue:

english

Fichier:

PDF, 121 KB

english, 2006

40

Clinical trials in metastatic hormone-refractory prostate cancer: Improving docetaxel therapy by targeting bone-related growth factors

Daniel P. Petrylak

Journal:

Current Oncology Reports

Année:

2007

Langue:

english

Fichier:

PDF, 103 KB

english, 2007

41

Chemotherapy agents and timing of chemotherapy in prostate cancer management

Kathleen M. Donohue, Daniel P. Petrylak

Journal:

Current Prostate Reports

Année:

2005

Langue:

english

Fichier:

PDF, 157 KB

english, 2005

42

Chemotherapy agents and timing of chemotherapy in prostate cancer management

Kathleen M. Donohue, Daniel P. Petrylak

Journal:

Current Urology Reports

Année:

2005

Langue:

english

Fichier:

PDF, 158 KB

english, 2005

43

Complications of androgen-deprivation therapy in men with prostate cancer

Allen C. Chen, Daniel P. Petrylak

Journal:

Current Urology Reports

Année:

2005

Langue:

english

Fichier:

PDF, 315 KB

english, 2005

44

Current Clinical Trials in Castrate-Resistant Prostate Cancer

Daniel P. Petrylak

Journal:

Current Urology Reports

Année:

2011

Langue:

english

Fichier:

PDF, 137 KB

english, 2011

45

Photochemical metalhalide bond cleavage reactions. A reexamination of the photochemistry of Re(CO)5Br

David R. Tyler, Daniel P. Petrylak

Journal:

Inorganica Chimica Acta

Année:

1981

Langue:

english

Fichier:

PDF, 255 KB

english, 1981

46

High dose calcitriol may reduce thrombosis in cancer patients

Tomasz M. Beer, Peter M. Venner, Christopher W. Ryan, Daniel P. Petrylak, Gurkamal Chatta, J. Dean Ruether, Kim N. Chi, John G. Curd, Thomas G. DeLoughery

Journal:

British Journal of Haematology

Année:

2006

Langue:

english

Fichier:

PDF, 55 KB

english, 2006

47

Third Joint Meeting of the American Urological Association and the Japanese Urological Association International Program at the 103rd Annual Meeting of the American Urological Association at Orlando 2008

Daniel P Petrylak, Hideyuki Akaza, Dean G Assimos, Yoshihide Ogawa, Martin E Gleave, Tomohiko Ichikawa, Peter T Nieh, Authony V D'Amico, Hiromitsu Mimata, Yoshihiko Tomita, Michael B Chancellor, Momok

Journal:

International Journal of Urology

Année:

2008

Langue:

english

Fichier:

PDF, 73 KB

english, 2008

48

Therapeutic options in androgen-independent prostate cancer: building on docetaxel

DANIEL PETRYLAK

Journal:

BJU International

Année:

2005

Langue:

english

Fichier:

PDF, 83 KB

english, 2005

49

Outcome after cytoreductive nephrectomy for metastatic renal cell carcinoma is predicted by fractional percentage of tumour volume removed

Phillip M. Pierorazio, James M. McKiernan, Tara R. McCann, Supriya Mohile, Daniel Petrylak, Mitchell C. Benson

Journal:

BJU International

Année:

2007

Langue:

english

Fichier:

PDF, 113 KB

english, 2007

50

Reply

Phillip M. Pierorazio, Mitchell Benson, James McKiernan, Mohile Supriya, Daniel Petrylak

Journal:

BJU International

Année:

2008

Langue:

english

Fichier:

PDF, 87 KB

english, 2008